Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-08-23 4:30 pm Purchase | 2021-08-11 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA CAPITAL MANAGEMENT L.P. | 165,749 5.220% | 60,762![]() (+57.88%) | Filing History |
2021-08-19 4:30 pm Purchase | 2021-08-09 | 13D | Climb Bio, Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 13,151,959 50.000% | 13,151,959![]() (New Position) | Filing History |
2021-08-18 5:30 pm Purchase | 2009-02-28 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT L.P. | 7,823,207 15.390% | 48,000![]() (+0.62%) | Filing History |
2021-08-16 4:32 pm Unchanged | 2021-08-16 | 13G | Adverum Biotechnologies, Inc. ADVM | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
2021-08-13 4:31 pm Purchase | 2021-08-03 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | RA CAPITAL MANAGEMENT L.P. | 1,606,859 5.600% | 1,606,859![]() (New Position) | Filing History |
2021-08-13 4:30 pm Purchase | 2021-08-03 | 13G | RxSight, Inc. RXST | RA CAPITAL MANAGEMENT L.P. | 3,052,796 11.100% | 3,052,796![]() (New Position) | Filing History |
2021-08-12 4:30 pm Purchase | 2021-08-02 | 13D | Icosavax, Inc. ICVX | RA CAPITAL MANAGEMENT L.P. | 5,779,347 14.700% | 5,779,347![]() (New Position) | Filing History |
2021-08-09 5:17 pm Purchase | 2021-07-30 | 13G | DA32 Life Science Tech Acquisition Corp. DALS | RA CAPITAL MANAGEMENT L.P. | 1,500,000 7.300% | 1,500,000![]() (New Position) | Filing History |
2021-08-09 4:32 pm Purchase | 2021-07-30 | 13G | Tenaya Therapeutics, Inc. TNYA | RA CAPITAL MANAGEMENT L.P. | 3,551,508 8.600% | 3,551,508![]() (New Position) | Filing History |
2021-08-06 4:30 pm Purchase | 2021-07-27 | 13D | Cytek Biosciences, Inc. CTKB | RA CAPITAL MANAGEMENT L.P. | 9,607,028 7.200% | 9,607,028![]() (New Position) | Filing History |
2021-07-28 4:30 pm Purchase | 2021-07-20 | 13G | TScan Therapeutics, Inc. TCRX | RA CAPITAL MANAGEMENT L.P. | 1,255,317 6.700% | 1,255,317![]() (New Position) | Filing History |
2021-07-23 4:30 pm Purchase | 2021-07-13 | 13G | ARYA Sciences Acquisition Corp V ARYE | RA CAPITAL MANAGEMENT L.P. | 1,000,000 6.500% | 1,000,000![]() (New Position) | Filing History |
2021-07-20 4:31 pm Purchase | 2021-07-20 | 13G | POINT Biopharma Global Inc. PNT | RA CAPITAL MANAGEMENT L.P. | 8,856,018 9.800% | 8,856,018![]() (New Position) | Filing History |
2021-07-16 4:30 pm Purchase | 2021-07-06 | 13D | Acumen Pharmaceuticals, Inc. ABOS | RA CAPITAL MANAGEMENT L.P. | 9,770,773 25.300% | 9,770,773![]() (New Position) | Filing History |
2021-07-12 5:13 pm Purchase | 2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE | RA CAPITAL MANAGEMENT L.P. | 8,263,982 33.900% | 8,263,982![]() (New Position) | Filing History |
2021-07-12 4:30 pm Purchase | 2021-06-30 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA CAPITAL MANAGEMENT L.P. | 104,987 3.300% | 104,987![]() (New Position) | Filing History |
2021-07-09 4:31 pm Purchase | 2021-06-29 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 2,978,955 5.900% | 2,978,955![]() (New Position) | Filing History |
2021-06-30 4:33 pm Purchase | 2021-06-23 | 13G | Entera Bio Ltd. ENTX | RA CAPITAL MANAGEMENT L.P. | 2,353,000 9.900% | 2,353,000![]() (New Position) | Filing History |
2021-06-30 4:32 pm Purchase | 2021-06-24 | 13D | Therapeutics Acquisition Corp. RACA | RA CAPITAL MANAGEMENT L.P. | 1,098,318 7.800% | 1,098,318![]() (New Position) | Filing History |
2021-06-29 4:33 pm Purchase | 2021-06-22 | 13G | CYTEIR THERAPEUTICS INC CYTT | RA CAPITAL MANAGEMENT L.P. | 3,247,117 9.400% | 3,247,117![]() (New Position) | Filing History |